SEMAX 10mg

Semax is a synthetic heptapeptide analog of the adrenocorticotropic hormone (ACTH) fragment ACTH(4–10). Originally developed in Russia for neuroscience research, Semax has been studied for its effects on central nervous system function, including cognitive processes, neurotrophic signaling, and neurotransmitter modulation. It has garnered significant research interest as a tool for investigating peptide-mediated neuroplasticity and brain-derived neurotrophic factor (BDNF) expression in preclinical models.

Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a 7-amino-acid peptide corresponding to the ACTH(4–10) sequence with a C-terminal Pro-Gly-Pro extension to enhance metabolic stability and CNS penetration. Unlike full-length ACTH, Semax lacks corticosteroid-stimulating activity, allowing researchers to isolate its neurotrophic and neuromodulatory effects. Supplied as 10mg lyophilized peptide for in vitro and preclinical neuroscience research applications.

For research purposes only. Not for human or animal consumption. Store lyophilized peptide at -20°C. Protect from light and moisture. Reconstituted solutions should be handled promptly or stored at -20°C for short-term research applications only.

Semax has been investigated in preclinical models for its effects on neuroplasticity markers, brain-derived neurotrophic factor (BDNF) expression, and monoaminergic systems including dopamine and serotonin. Studies have also explored its neuroprotective properties in models of cerebral ischemia and its effects on gene expression related to synaptic plasticity and neural adaptation.